Home » Topics » Conferences

Conferences
RSS

Gilead selects GS-930 prodrug for further evaluation

Feb. 3, 1997

Aronex describes anti-HCMV compound

Feb. 3, 1997

Genotypic analysis of patients treated with adefovir dipivoxil

Jan. 31, 1997

Cel-Sci presents results with heteroconjugate technology for HIV vaccine development

Jan. 31, 1997

NCI discloses anti-HIV agent with novel mechanism of action

Jan. 31, 1997

Abbott develops protease inhibitor for combination therapy

Jan. 31, 1997

Thalidomide: Forty years later

Jan. 30, 1997

Cidofovir highlighted at retroviral conference

Jan. 30, 1997

Pilot trial of folic acid in stroke patients

Jan. 30, 1997

Famvir safe and effective in HIV-infected patients with shingles

Jan. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...